Cryptocurrency & Digital Assets

As Leverage Shares by Themes launches seven new 2x daily leveraged ETFs, a look at the high-stakes game of amplified returns and the risks for investors.

A new partnership aims to power a tech boom in Southwest Virginia with a massive gas-fired plant, sparking hopes for revival and questions about energy.

A new alliance led by engineering giant AtkinsRéalis will deliver the Midlands Rail Hub, a project promising vast economic growth and 300 extra trains daily.

Vancouver-based TRUBAR agrees to a C$201M buyout by Turkish food conglomerate ETİ Gıda, marking a major move in the booming plant-based snack market.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

Belgian metals giant Campine invests in advanced antimony recycling and moves to continuous trading, navigating a volatile market with record-breaking earnings.

Ninepoint Partners doubles its energy fund's target yield to a massive 14%. We dig into the sustainability, risks, and the new reality of energy profits.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

A new report reveals the pressure for a perfect holiday drives more urgent service calls than burst pipes, reshaping the meaning of a Christmas crisis.

Amid surging investor confidence, Copper Road Resources has twice increased its private placement, securing nearly $1M for critical mineral exploration in Ontario.

Vanguard Canada projects zero capital gains distributions for three key bond ETFs, offering investors a tax reprieve and a signal on the 2025 market.

Businesses are shifting from cheap trinkets to useful giveaways. Discover how practical promotional items build lasting loyalty and deliver powerful ROI.

New exam results show advisors embracing certification as provinces tighten rules on who can offer financial advice, boosting consumer protection.

Incyte's Minjuvi, a first-of-its-kind immunotherapy, gains EC approval for follicular lymphoma, offering patients a powerful new chemo-free option.

After 40 years, CEO Michael Magnavita will retire in 2026. Internal successor Drew Stanley is set to lead the award-winning institution's next chapter.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

Dartmouth Cancer Center gains a top designation for using GammaTile, an innovative implant that delivers immediate radiation during brain tumor surgery.

The fan-favorite Quesarito is back, fueled by a decade-old viral meme involving Nikola Jokić. But will the NBA MVP finally take a bite? He says no.